Neuberger Berman Group’s Emergent Biosolutions EBS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-686,449
| Closed | -$14.4M | – | 1808 |
|
|
2022
Q3 | $14.4M | Buy |
686,449
+36,348
| +6% | +$763K | 0.02% | 657 |
|
|
2022
Q2 | $20.2M | Buy |
650,101
+7,070
| +1% | +$219K | 0.02% | 621 |
|
|
2022
Q1 | $26.4M | Sell |
643,031
-3,364
| -0.5% | -$138K | 0.02% | 608 |
|
|
2021
Q4 | $27.8M | Sell |
646,395
-2,662,667
| -80% | -$114M | 0.02% | 608 |
|
|
2021
Q3 | $165M | Sell |
3,309,062
-109,544
| -3% | -$5.46M | 0.14% | 214 |
|
|
2021
Q2 | $214M | Buy |
3,418,606
+213,050
| +7% | +$13.3M | 0.19% | 154 |
|
|
2021
Q1 | $297M | Sell |
3,205,556
-5,793
| -0.2% | -$537K | 0.28% | 83 |
|
|
2020
Q4 | $287M | Buy |
3,211,349
+274,955
| +9% | +$24.6M | 0.3% | 81 |
|
|
2020
Q3 | $303M | Sell |
2,936,394
-52,079
| -2% | -$5.37M | 0.36% | 64 |
|
|
2020
Q2 | $236M | Buy |
2,988,473
+635,676
| +27% | +$50.2M | 0.29% | 87 |
|
|
2020
Q1 | $136M | Sell |
2,352,797
-98,040
| -4% | -$5.67M | 0.21% | 136 |
|
|
2019
Q4 | $132M | Buy |
2,450,837
+19,203
| +0.8% | +$1.04M | 0.15% | 198 |
|
|
2019
Q3 | $127M | Buy |
2,431,634
+215,081
| +10% | +$11.2M | 0.16% | 187 |
|
|
2019
Q2 | $107M | Buy |
2,216,553
+294,445
| +15% | +$14.2M | 0.13% | 236 |
|
|
2019
Q1 | $97.1M | Buy |
1,922,108
+617,486
| +47% | +$31.2M | 0.12% | 251 |
|
|
2018
Q4 | $77.3M | Buy |
1,304,622
+969,452
| +289% | +$57.5M | 0.11% | 274 |
|
|
2018
Q3 | $22.1M | Buy |
+335,170
| New | +$22.1M | 0.03% | 618 |
|